NEW YORK (GenomeWeb News) – Atlas Genetics has gained £2.1 million ($4.1 million) in venture capital from previous and new investors, which it will use to conduct clinical evaluations for a clinical diagnostic test for Group B Streptococcus in pregnant women.
 
Investors in this round of financing included South West Ventures Fund, GEIF, and private investors through the SWAIN business angel’s network. New investors included Finance South West Growth Fund and Braveheart Ventures.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.